Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
McKesson
AstraZeneca
Boehringer Ingelheim
McKinsey
Express Scripts

Last Updated: May 21, 2022

CLINICAL TRIALS PROFILE FOR SEROMYCIN


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Seromycin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00182000 ↗ Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy Completed Hartford Hospital Phase 3 2003-11-01 This study will assess the effectiveness of Seromycin (D-cycloserine) in enhancing the positive effects of behavior therapy for people with Obsessive-Compulsive Disorder (OCD).
NCT00182000 ↗ Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy Completed Massachusetts General Hospital Phase 3 2003-11-01 This study will assess the effectiveness of Seromycin (D-cycloserine) in enhancing the positive effects of behavior therapy for people with Obsessive-Compulsive Disorder (OCD).
NCT00198120 ↗ Safety and Effectiveness of D-Cycloserine in Children With Autism Completed Indiana University School of Medicine Phase 3 2004-02-01 This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
NCT00198120 ↗ Safety and Effectiveness of D-Cycloserine in Children With Autism Completed National Alliance for Research on Schizophrenia and Depression Phase 3 2004-02-01 This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
NCT00198120 ↗ Safety and Effectiveness of D-Cycloserine in Children With Autism Completed National Institute of Mental Health (NIMH) Phase 3 2004-02-01 This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
NCT00198120 ↗ Safety and Effectiveness of D-Cycloserine in Children With Autism Completed Indiana University Phase 3 2004-02-01 This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Seromycin

Condition Name

Condition Name for Seromycin
Intervention Trials
Obsessive-Compulsive Disorder 4
Schizophrenia 3
Autistic Disorder 2
Posttraumatic Stress Disorder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Seromycin
Intervention Trials
Disease 7
Stress Disorders, Post-Traumatic 4
Obsessive-Compulsive Disorder 4
Compulsive Personality Disorder 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Seromycin

Trials by Country

Trials by Country for Seromycin
Location Trials
United States 26
Canada 4
Israel 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Seromycin
Location Trials
Massachusetts 5
Illinois 2
Georgia 2
Texas 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Seromycin

Clinical Trial Phase

Clinical Trial Phase for Seromycin
Clinical Trial Phase Trials
Phase 4 7
Phase 3 4
Phase 2 11
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Seromycin
Clinical Trial Phase Trials
Completed 19
Unknown status 4
Withdrawn 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Seromycin

Sponsor Name

Sponsor Name for Seromycin
Sponsor Trials
National Institute of Mental Health (NIMH) 5
Massachusetts General Hospital 4
University of Calgary 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Seromycin
Sponsor Trials
Other 44
NIH 9
U.S. Fed 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
McKinsey
Dow
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.